Immunoproteasome function maintains oncogenic gene expression in KMT2A-complex driven leukemia
Nuria Tubío-Santamaría(Universitätsmedizin Greifswald), Florian H. Heidel(Medizinische Hochschule Hannover)
Cited by 14
Related Papers
Clinical outcomes of ruxolitinib treatment in 595 intermediate‐1 risk patients with myelofibrosis: The RUX‐MF Real‐World Study
|Cancer|2024|10
Impact of ELN clinical signs and symptoms on the thrombotic risk in polycythemia vera patients treated with front-line hydroxyurea
|Leukemia|2025|6